Evaluation of the Efficacy of ROPIVACAINE in Children and Young Adults With Hereditary Epidermolysis Bullosa
Clinical trial NCT03730584 · COMPLETED
Trial details
- NCT number
- NCT03730584
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-27
- Primary completion
- 2019-11-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.